chrisvoncsefalvay/vaers-outcomes huggingface dataset:
suspected vaccination failure/had my third outbreak; diagnosed with kidney stones; had my third outbreak; my arm was pretty sore; had weakness in that arm; incredibly painful; blisters showed up; itch; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (had them two times before receiving Shingles vaccines).   On an unknown date, the patient received Shingles vaccine. On an unknown date, 1 month after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), renal stone (serious criteria GSK medically significant), shingles, pain in arm, weakness of arms, pain, blister and pruritus. On an unknown date, the outcome of the vaccination failure, renal stone, shingles, pain, blister and pruritus were unknown and the outcome of the pain in arm and weakness of arms were recovered/resolved.   It was unknown if the reporter considered the vaccination failure, renal stone, shingles, pain in arm, weakness of arms, pain, blister and pruritus to be related to Shingles vaccine.  Additional details were provided as follows The patient self-reported this case. The age at vaccination was not reported. The patient had shingles three times. The patient was too young to get the Shingles vaccine and the finally received Shingles vaccine 2 years ago from the date of reporting. A month after receiving Shingles vaccine, the patient had third outbreak. The patient stated that they were incredibly painful.  The patient's arm was pretty sore for a couple of days, but he/she had weakness in that arm for a month or two. The patient also experienced itch. The patient was actually diagnosed with kidney stones until the blisters finally showed up. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule and laboratory test confirming shingles were unknown at the time of reporting.
2 weeks, persistent, Left deltoid, pain + painful, range of motion since the vaccine on 11/14/02.
Patient received vaccines spoke with the MA for a couple minutes, got up and starting walking out of the clinic. Tripped and fell into wall, MA helped sturdy patient and assist to walk out. Pt took a couple more steps and experienced vasovagal syncope and fell to the ground. Multiple MAs help get patient off the ground and into a chair. Doctor arrived at the scene and instructed to place patient flat on the ground with legs elevated. MA used ammonia inhalant, patient came to. MAs assisted patient into reclining wheel chair. Laid patient all the way back with ice pack on back if neck. Patient did drink some juice. Parent was called to drive patient home.
1st vaccine: Within 2 weeks of 1st vaccination, my menstrual cycle began 2 weeks early and lasted for 7 full days  (VERY HEAVY), which is very abnormal for me. I also had a rash on my left arm after first vaccination for a couple days. The 2 days following the first vaccine, I had no taste or smell (except sweet). 2nd vaccination: In the first 12 hours, arm started to hurt than whole body hurt intensely. Within one day, I was confined to bed. I could not see or hear. I experieinced cold sweats with hot and cold flashes.  My face swelled and I had broken capillaries on my face as well as 22 pimples. (I've never had that before). It felt like I had a migraine in every joint and vertebrae in my body.  My breathing became labored within 36 hours of getting vaccine. Today, almost 2 weeks later, I still experieince consistent fatigue and intermittent heat and cold waves,
PATIENT REC'D A 3RD SHINGRIX IN ERROR AT 11 AM ON 11/18/20.  HE VISITED THE ER AT 12:30 AM ON 11/19/20 WITH COMPLAINTS OF WEAKNESS, CHILLS AND CLAMMY SKIN
3 days after 1st pfizer shot, I almost fainted and I have been experiencing vertigo ever since, it is not getting any better almost 2 weeks later.
Itchiness, redness, hives for about 1 1/2 wks. All symptoms were around the area of the vaccination. Hive started 24 hours after injection.
Information has been received from a physician concerning a female (age unknown) who was vaccinated intramuscularly with a 0.5 mL dose of Pneumovax 23 (Lot #651356/0089F).  On approximately 13-NOV-2006 ("within the last week") the patient developed redness and a rash from the shoulder to the elbow.  The patient sought unspecified medical attention.  At the time of this report, the outcome was unknown.  No product quality complaint was involved.  Additional information has been requested.
Headache, Myalgia, Fever, 01/20/21 - headache and some muscle aches with sore arm. Woke up 01/21/21 with fever, chills, body aches, bad headache, extreme tiredness. Narrative:
14 Doses administered beyond expiration date(Date the vial was initially stored in the refrigerator: 25Oct2021); Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (14 Doses administered beyond expiration date(Date the vial was initially stored in the refrigerator: 25Oct2021)) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination.No Medical History information was reported. On 19-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (14 Doses administered beyond expiration date(Date the vial was initially stored in the refrigerator: 25Oct2021)). On 19-Nov-2021, EXPIRED PRODUCT ADMINISTERED (14 Doses administered beyond expiration date(Date the vial was initially stored in the refrigerator: 25Oct2021)) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.No concomitant medications reported.No treatment information was provided.Reporter informed that 13 booster doses and one first dose (total of 14 doses) were administered with an expired vaccine. On 25-Oct-2021, the vial was initially stored in the refrigerator. No temperature excursion was reported.
Case of chickenpox in a fully vaccinated child. Child was not diagnosed by a physician, but sibling was and this child had the same symptoms.
The pt experienced several maculo-papulo lesions on face, behind ears, trunk and arms few with vesicles, one with scab on leftl mandible. Treated with Benadryl and calamine lotion.
10/10 arm/shoulder pain, unable to perform ROM, OTC pain meds ineffective, intermittent numbness/tingling, swelling  ED visit x2 on 2/26/23 Rx: Benedryl, XR L arm, heat, cold, compression, NSAIDS, muscle relaxers, arm sling
This spontaneous case, initially received from other non-health professional on 14-Nov-2018, concerning a female patient of unspecified age. On an unspecified date, the FLUCELVAX QIVc vaccine underwent first temperature excursion with Tmax 8.2 degree Centigrade for 4 minutes. On 22-Oct-2018, vaccine underwent second temperature excursion with Tmax 9.8 degree Centigrade for 23 minutes. On an unspecified date, two temperature excursions were identified after an audit. On 24-Oct-2018, the patient was inadvertently administered FLUCELVAX QIVc (dose: 0.5 ml, route of administration: intramuscular, anatomical location: right deltoid, batch number: 252672 and expiry date: 30-Jun-2019) which underwent temperature excursion. The patient did not experience any adverse events after administration. This case is linked to (201805262) due to same reporter.
This spontaneous report as received from pharmacy student refers to a 37 year old female patient with diabetes and asplenia. Approximately on an unknown date of 2008 the patient was vaccinated with PNEUMOVAX23 injection (dose number, lot number and expiry date and route unknown). It was reported that patient has been administered PNEUMOVAX23 yearly for the last 6 years. No adverse effect was reported. The outcome of has been administered PNEUMOVAX23 yearly for the last 6 years and no adverse event was unknown. No further information provided. Additional information has been requested.
arm was hot; arm was itching; arm was red; arm was swollen; Arm was rashy; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (arm was hot), PRURITUS (arm was itching), ERYTHEMA (arm was red), PERIPHERAL SWELLING (arm was swollen) and RASH (Arm was rashy) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 052E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Aug-2021, the patient experienced FEELING HOT (arm was hot), PRURITUS (arm was itching), ERYTHEMA (arm was red), PERIPHERAL SWELLING (arm was swollen) and RASH (Arm was rashy). The patient was treated with HYDROCORTISONE (HYDROCORTICONE) for Adverse event, at a dose of 1 dosage form. On 16-Aug-2021, PERIPHERAL SWELLING (arm was swollen) had resolved. At the time of the report, FEELING HOT (arm was hot), PRURITUS (arm was itching) and RASH (Arm was rashy) outcome was unknown and ERYTHEMA (arm was red) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided by  the reporter.   Reporter did not allow further contact
TINGLING SENSATION IN LEFT ARM AND LEFT LEG; SWELLING OF EYES; SWELLING OF LEGS; This spontaneous report received from a patient concerned a 61 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 1820095, and expiry: UNKNOWN) dose was not reported, administered on 09-AUG-2021 09:15 for prophylactic vaccination. No concomitant medications were reported. On 09-AUG-2021, the patient experienced swelling of eyes. On 09-AUG-2021, the patient experienced swelling of legs. On 11-AUG-2021, the patient experienced tingling sensation in left arm and left leg. The action taken with covid-19 vaccine was not applicable. The outcome of the swelling of legs, tingling sensation in left arm and left leg and swelling of eyes was not reported. This report was non-serious.
24 hours after shot began headache- for next 36-40 hours extreme nausea & headache (sinus & jaw) Routine chiropractic app't & therapy helped & muscle where then bed & sleep for 10 hours Redness at shot area
Painful and swollen glands and lymph nodes; Swollen throat; When she got the shot, she got little bit anxious; Painful and swollen glands and lymph nodes; This is a spontaneous report received from contactable reporter(s) (Consumer or other non-HCP) from medical information team. The reporter is the patient.  A 41-year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 03Aug2021 (Lot number: FA7485, Expiration Date: 31Oct2021) at the age of 41 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: LYMPH NODE PAIN (non-serious) with onset Aug2021, outcome "unknown", LYMPHADENOPATHY (non-serious) with onset 05Aug2021, outcome "unknown" and all described as "Painful and swollen glands and lymph nodes"; PHARYNGEAL SWELLING (non-serious) with onset 05Aug2021, outcome "unknown", described as "Swollen throat"; ANXIETY (non-serious) with onset 03Aug2021, outcome "unknown", described as "When she got the shot, she got little bit anxious". Therapeutic measures were taken as a result of lymph node pain, lymphadenopathy.  Additional information: Received call from consumer regarding the Pfizer COVID vaccine. She talked to her pharmacy and had her first dose on 03Aug2021Tuesday. She called pharmacy and they gave her the company number. She has swollen glands and lymph nodes and it is kind of like pain, but she took some Tylenol. She wanted to know if this was normal and if there is anything else to do to treat it or does she let it runs its course.   No follow-up attempts are possible. No further information is expected.
Large red circle; swollen around injection site; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: ER8734) via an unspecified route of administration in the left arm on 10Apr2021 at 13:30 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient had no allergies to medications, food, or other products. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 12Apr2021 the patient experienced large red circle and swollen around injection site. No therapeutic measures were taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events of large red circle and swollen around vaccination site was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Papular lesions on stomach x 1 day.  No fever Rash on trunk and legs at time of office visit today.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. The patient's pertinent medical history and drug reactions or allergies were not reported. On 22-OCT-2015, the patient was vaccinated orally with a first, 2 ml doe of ROTATEQ (lot number reported as L008518 and expiration date 15-DEC-2016) at a little over six months of age. Concomitant therapy was not reported. No adverse effect was reported. Additional information has been requested.
3 days after receiving the shot I noticed a grape size lump above my right collar bone.  After further research this is a swollen lymph node.  I have no pain or any other noticeable issues.
Pt rec'd flu vaccine on 11/1/01 and notified Sauna on 11/2/01. On L deltoid she developed 3" circular red raised area which was sore. She stated she had the same reaction to flu shot last year. She did not seek Medical attention.
presented to the ED after sustaining a ground level mechanical fall at home underwent left hip hemiarthroplasty with several post op complications. Upon discharge pt tested positive for covid asymptomatic. Pt discharged to hospice.
PT REC'D ANTHRAX #1 ON 6/16/03. TWO DAYS LATER HE DEVLOPED A SEVERE HEADACHE, TENSION IN HIS NECK. A SORE THROAT, AND NON-PRODUCTIVE COUGH. HE RATED THE HEADACHE 10/10 ON PAIN SCALE. HE THEN DEVELOPED PAIN BEHIND BOTH EYES WHICH CAUSED SEVERE PAIN WHEN LOOKING FROM SIDE TO SIDE. HE ALSO HAD CERVICAL ADENOPATHY. AFTER ONE WEEK HE WAS PLACED ON AN ANTIBIOTIC. HIS SYMPTOMS CONTINUED FOR GREATER THAN TWO WEEKS.
little hard in one spot; like her brain is not function 100%; red mark, 3 by 3 inches at the injection site; tired; pended all day sleeping more than awake; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE, INDURATION, FEELING ABNORMAL, INJECTION SITE ERYTHEMA, and FATIGUE in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     The patient's past medical history included Osteoporosis.   On 26-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced SOMNOLENCE. On an unknown date, the patient experienced INDURATION, FEELING ABNORMAL, INJECTION SITE ERYTHEMA, and FATIGUE. At the time of the report, SOMNOLENCE, INDURATION, FEELING ABNORMAL, INJECTION SITE ERYTHEMA, and FATIGUE outcome was unknown.            No concomitants were reported. No treatment was reported. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) was not applicable.   This case was linked to MOD-2021-060836.
PT received shot and 5 minutes later complained of headache, ears were hot, chest tightness.  PT taken to EMS onsite for evaluation.  Vitals taken.  Elevated BP.   Benadryl administered at 4:30 pm.  Medic unit called further vitals and EKG taken.  PT started to feel better at 1725.  PT refused transport.  PT exited site at 1740.
This case was reported by a healthcare professional via a sales representative and described the occurrence of fever in a subject of unspecified age and gender who was vaccinated with KINRIX, GlaxoSmithKline for prophylaxis. In February 2010 the subject received 1st dose of KINRIX in and unknown arm. In February 2010, at an unspecified time after vaccination with KINRIX, the subject experienced fever over 103 degrees. At the time of reporting the outcome of the event was unspecified. The healthcare professional considered the even was probably related to vaccination with KINRIX. Information received via QA indicated that they have not received any other product complaints for this lot number of KINRIX. No product was available for return to GlaxoSmithKline. Quality assurance results received on 02 March 2010, concluded that based on the fact that no precise technical problem was reported, no technical investigation has been performed accordingly; GlaxoSmithKline Biologicals considers this complaint as not verified. This is second of two reports made by the healthcare professional, for the other case see A0846107A.
Flu vaccine was administered very high on my left arm, very close to the shoulder bone. It burned tremendously when it was pushed into the tissue, more than any vaccine I've ever had.  I have received the flu vaccine all of my adult life with zero adverse reaction until this year.  Since the date of injection, I have had a tremendous increase in left shoulder pain, and a marked decrease in range of motion.  It is now 3 weeks post injection and I'm feeling worse than ever.  I had a shoulder MRI and was told I have tendonitis and bursitis.  I was referred to a sports medicine orthopedic doctor, and saw him yesterday.  My left arm is now in a sling, I will be icing my shoulder 4x a day, and I am on a rigorous dosage of Prednisone.  I am hoping and praying that I get some relief, this has been absolutely miserable.
Patient is a 24 year old female who has completed a 1 hour-minute observation period with the following signs and symptoms of an adverse reaction: swelling of the lips, tongue or face. Itchiness of throat Moderna COVID-19 vaccine# 1 in series administered.  o Action(s) taken: Other - benadryl  o 930: pt reported swelling of face (lips and cheeks) and itchiness of throat o Pt reported no problems of breathing or swelling in throat o 940 : benadryl given to patient pt vitals 125/75 SpO2 100 pulse 74 and RR 18 o 1008: DOD contacted agreed with benadryl administration plus video assessment of patient initiated at 1020 o 1020 DOD okayed discharge after 1 hour of observation pt was also sent prescription for steroid and antihistamine o 1055: last set of vitals 110/68 SpO2 100 RR 18  o  1100 pt  Discharged, pt stated she felt okay.   o Allergy to COVID-19 vaccine documented in Allergies activity: Yes o Patient advised to discuss second dose considerations with a clinician
Patient died 2 hours after getting the vaccine; This spontaneous case was reported by a non-health professional and describes the occurrence of DEATH (Patient died 2 hours after getting the vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Death occurred on an unknown date The cause of death was not reported. It is unknown if an autopsy was performed.            No concomitant products were reported. The reporter was worried about the administration of the vaccine and wanted to know if there was a way for someone to help their community. Reporter had contacted everyone in Public health department of the rural hometown. With the amount of adverse reactions with vaccine reporter was concerned that the vaccine was not being stored properly or not been given properly and further reported that one person died and they were not reporting it because they did not trust the government. A patient died two hours after getting the Moderna vaccine.  No treatment information provided.  This is a case of sudden death in a female patient who died 2 hours after receiving a dose of vaccine. Very limited information regarding this event has been provided at this time.; Sender's Comments: This is a case of sudden death in a female patient who died 2 hours after receiving a dose of vaccine. Very limited information regarding this event has been provided at this time.; Reported Cause(s) of Death: Unknown cause of death
Severe soreness in arm and shoulder soon after administration and continuing for at least one day. Tiredness.  Soreness less severe after 24 hours.
Case of contact transmission - this patient was the contact and not the vaccinee. On 9 Apr 2015, smallpox Vaccinee received his primary smallpox vaccine. Around 10 or 11 Apr 2015, Contact received new tattoo wrapping around his left arm (just below elbow) to his shoulder. On 11 Apr 2015, Vaccinee was in the rain and his shirt became wet. He took off his shirt and threw it in the backseat of his car, where the Contact's LUE (recently tattooed) came into contact with the shirt. (Contact leaned against shirt x approximately 10 minutes). On 15 Apr 2015, contact developed blisters on his left upper arm. On 17 Apr 2015, contact went to Emergency Dept with left axillary swelling. On 18 Apr 2015, contact reports fever, body aches, arm swelling, and pain, as well as new blisters and desquamation over tattoo surface. (In addition to contact transmission, Contact developed secondary infection of LUE affected by tattoo - see cultures).
Fever, chills, nausea, total body aches, headache started 8:30 pm day of vaccine. Took TYLENOL. Still having symptoms 24 hours later.
Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Confusion-Medium, Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Flushed / Sweating-Severe, Systemic: Weakness-Severe, Additional Details: Patient returned for 2nd dose of Pfizer and stated no issues with 1st dose. During her 15 min observation her mother said patient complained she felt like she would faint. She was sweating, extremely hot, lethargic and dizzy while she was sitting on chair. Mom agreed that I should call 911 and paramedics took vitals and transported her to ER. I followed up and mom said she was better but getting tests at ER.
This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. There was no information provided about the patient's concurrent conditions, medical history, concomitant medications, drug reactions or allergies. On 04-APR-2017, the patient inadvertently received an expired dose of injectable VARIVAX for prophylaxis (lot # K021483 with expiration date on 03-NOV-2016) (strength, dose, frequency, route of administration and anatomical location were not provided). Additional information is not expected because the reporter did not consent for further follow up.
Had 1st dose of GARDASIL 9 and within 3-5 min became pale, sweaty, could not see and B/P dropped.